← Leaderboards
Sharon R. Pine
University Of Colorado Denver
$4,344,969
Attributed
$4,344,969
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $441.2K · FY2011–25$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,344,969 · 3
By mechanism
R01$3,806,223 · 2
K22$538,746 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Lynn E Heasley$6,919,747
- David R Grosshans$9,101,858
- Nicholas K Foreman$4,734,103
- Michael T Lewis$21,208,742
- Andrew S Kraft$21,224,247
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingTumorCessation Of LifeLung NeoplasmsIn VivoPathway InteractionsMalignant Neoplasm Of LungMalignant NeoplasmsTherapy ResistantAutomobile DrivingMutantMolecularLung AdenocarcinomaMutationTumor ProgressionClustered Regularly Interspaced Short Palindromic RepeatsOncogenicAddictionTranscription FactorXenograft ProcedureSignal TransductionNon-Small-Cell Lung CarcinomaMolecular ProfilingCancer Survival
Grant awards (16)
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$433,114
R01 · FY2025 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$441,169
R01 · FY2024 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$373,775
R01 · FY2022 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$50,677
R01 · FY2022 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$430,226
R01 · FY2021 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$416,907
R01 · FY2020 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$323,486
R01 · FY2018 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$323,793
R01 · FY2017 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$40,000
R01 · FY2017 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$324,085
R01 · FY2016 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$324,363
R01 · FY2015 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$324,628
R01 · FY2014 · CA · contact PI
Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells$152,907
K22 · FY2013 · CA · contact PI
Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells$26,675
K22 · FY2013 · CA · contact PI
Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells$179,582
K22 · FY2012 · CA · contact PI
Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells$179,582
K22 · FY2011 · CA · contact PI